DE60202296D1 - Pharmazeutische verbindungen mit serotonin rezeptor aktivität - Google Patents
Pharmazeutische verbindungen mit serotonin rezeptor aktivitätInfo
- Publication number
- DE60202296D1 DE60202296D1 DE60202296T DE60202296T DE60202296D1 DE 60202296 D1 DE60202296 D1 DE 60202296D1 DE 60202296 T DE60202296 T DE 60202296T DE 60202296 T DE60202296 T DE 60202296T DE 60202296 D1 DE60202296 D1 DE 60202296D1
- Authority
- DE
- Germany
- Prior art keywords
- receptor activity
- pharmaceutical compounds
- serotonin receptor
- serotonin
- pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D333/70—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36161101P | 2001-07-11 | 2001-07-11 | |
EP01500181 | 2001-07-11 | ||
PCT/US2002/016594 WO2003006455A1 (en) | 2001-07-11 | 2002-06-27 | Pharmaceutical compounds with serotonin receptor activity |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60202296D1 true DE60202296D1 (de) | 2005-01-20 |
Family
ID=26077297
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60202296T Expired - Lifetime DE60202296D1 (de) | 2001-07-11 | 2002-06-27 | Pharmazeutische verbindungen mit serotonin rezeptor aktivität |
Country Status (2)
Country | Link |
---|---|
US (1) | US20040180883A1 (de) |
DE (1) | DE60202296D1 (de) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR122021013836B1 (pt) * | 2009-12-04 | 2022-05-24 | Sunovion Pharmaceuticals, Inc. | Composto e seu uso, composição farmacêutica |
MX2019000980A (es) | 2016-07-29 | 2019-07-04 | Sunovion Pharmaceuticals Inc | Compuestos y composiciones y usos de los mismos. |
JP2019523279A (ja) | 2016-07-29 | 2019-08-22 | サノビオン ファーマシューティカルズ インクSunovion Pharmaceuticals Inc. | 化合物および組成物ならびにそれらの使用 |
JP7146782B2 (ja) | 2017-02-16 | 2022-10-04 | サノビオン ファーマシューティカルズ インク | 統合失調症を処置する方法 |
MX2020000523A (es) | 2017-08-02 | 2020-08-20 | Sunovion Pharmaceuticals Inc | Compuestos de isocromano y usos de los mismos. |
CN118406063A (zh) | 2018-02-16 | 2024-07-30 | 赛诺维信制药公司 | 盐、晶型及其制备方法 |
US11136304B2 (en) | 2019-03-14 | 2021-10-05 | Sunovion Pharmaceuticals Inc. | Salts of a heterocyclic compound and crystalline forms, processes for preparing, therapeutic uses, and pharmaceutical compositions thereof |
MX2022012833A (es) | 2020-04-14 | 2022-11-07 | Sunovion Pharmaceuticals Inc | (s)-(4,5-dihidro-7h-tieno[2,3-c]piran-7-il)-n-metilmetanamina para tratar trastornos neurologicos y psiquiatricos. |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4247553A (en) * | 1977-10-31 | 1981-01-27 | The Upjohn Company | Methods of treating psychosis |
US6162803A (en) * | 1998-04-08 | 2000-12-19 | American Home Products Corp. | Indol-3-yl-cyclohexyl amine derivatives for the treatment of depression |
-
2002
- 2002-06-27 US US10/480,708 patent/US20040180883A1/en not_active Abandoned
- 2002-06-27 DE DE60202296T patent/DE60202296D1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US20040180883A1 (en) | 2004-09-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE320799T1 (de) | Retardierte, orale, pharmazeutische darreichnungsformen mit tramadol | |
DE60209145D1 (de) | Pharmazeutische formulierungen mit platinderivaten | |
NO20022970L (no) | Hydrogel-drevet medikamentdoseringsform | |
ATE372765T1 (de) | Feste pharmazeutische formulierungen mit telmisartan | |
ATE331529T1 (de) | Antigen enthaltende pharmazeutische zusammensetzung | |
ATE307571T1 (de) | Pharmazeutische formulierung enthaltend bicalutamid | |
ATE359064T1 (de) | Pharmazeutische tramadolsalze | |
ATE458486T1 (de) | Feste, oral applizierbare pharmazeutische darreichungsformen enthaltend rivaroxaban mit modifizierter freisetzung | |
ATE460169T1 (de) | Pharmazeutische formulierung mit lanthanum- verbindungen | |
DE60332393D1 (de) | Flüssige pharmazeutische zusammensetzung mit pyridonderivaten | |
NO20053150D0 (no) | System for administrasjon av medisin. | |
DE60213592D1 (de) | Flüssige pharmazeutische zusammensetzung | |
NO20030627L (no) | Hydrogel-drevet medikament doseringsform | |
DE60308372D1 (de) | Dosierungsverabreichungsvorrichtung | |
DE602004016967D1 (de) | Flüssige pharmazeutische palonosetronformulierungen | |
ATA59499A (de) | Pharmazeutische, tolperison enthaltende zubereitung zur oralen verabreichung | |
ATE327759T1 (de) | Pharmazeutische zusammensetzung mit verlungerter freisetzung | |
IT1311921B1 (it) | Composti farmaceutici. | |
DE60217390D1 (de) | Bicalutamid enthaltende pharmazeutische zusammensetzung | |
DE60202296D1 (de) | Pharmazeutische verbindungen mit serotonin rezeptor aktivität | |
DE60336999D1 (de) | Melatonin enthaltende pharmazeutische formulierung | |
DE60310526D1 (de) | Ivabradin enthaltende pharmazeutische zusammensetzung mit oraler dispersion | |
DE60136367D1 (de) | Pharmazeutische zusammensetzung mit modifiziertem träger | |
IS7383A (is) | Skammtaform með stýrða lyflosun til inngjafar | |
DE10291905D2 (de) | Pharmazeutische Zusammensetzung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8332 | No legal effect for de |